Implications for Australia of the multimodal treatment study of children with attention-deficit/hyperactivity

F Levy1

  • 1School of Psychiatry, University of New South Wales, and Avoca Clinic, Prince of Wales Hospital, Randwick, Australia. f.levy@unsw.edu.au

Insights

The Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder (MTA) found combined treatments effective for ADHD, influencing Australian clinical service planning. Further research is needed on ethical considerations and technological advancements in child psychiatry.

Area of Science:

  • Child and Adolescent Psychiatry
  • Behavioral Science
  • Health Services Research

Background:

  • The Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder (MTA) is a large-scale study with significant implications for clinical services.
  • Attention-deficit/hyperactivity disorder (ADHD) affects numerous children, necessitating effective treatment and service planning.

Purpose of the Study:

  • To review the implications of the USA MTA study for planning clinical services for children with ADHD in Australia.
  • To examine the findings of the MTA study regarding treatment efficacy and their relevance to Australian service delivery.
  • To discuss ethical, philosophical, and technological considerations impacting ADHD services.

Main Methods:

  • Analysis of MTA study findings comparing medication alone versus combined medication and behavior therapy.
  • Discussion of Australian service traditions, workforce, diagnostic, ethical, and philosophical factors.
  • Examination of pharmacogenomic research and its implications for ADHD treatment.

Main Results:

  • Combined treatments enable lower medication doses and are effective for comorbid ADHD symptoms.
  • Multimodal treatments show efficacy for complex cases.
  • Technological advancements, including pharmacogenomics, are poised to influence future ADHD management.

Conclusions:

  • The MTA study highlights the need for careful service planning and consideration of the optimal level of medicalization in ADHD care.
  • Ethical and philosophical debates surrounding medication use for subthreshold symptoms and socialization are crucial.
  • Child psychiatrists must engage with technological advancements to inform future practice and policy.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...